MedicarePartD.guide

A non-government resource built from CMS public data

Long-acting (basal) insulin on every 2026 Puerto Rico Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 3 stand-alone Part D plans in Puerto Rico cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Long-acting (basal) insulin by 2026 Puerto Rico Part D plan
DrugHealthSpring Extra Rx$50.00/moS5617-385HealthSpring Assurance Rx$65.70/moS5617-348AARP Medicare Rx Preferred from UHC$145.10/moS5820-037
Lantusinsulin glargineTier 317%Tier 322%Tier 325%
insulin glargineunbranded LantusNot coveredNot coveredTier 325%
Basaglarinsulin glargineNot coveredNot coveredNot covered
Semgleeinsulin glargine-yfgnNot coveredNot coveredNot covered
Rezvoglarinsulin glargine-aglrNot coveredNot coveredNot covered
Toujeoinsulin glargine, U-300Tier 317%Tier 322%Tier 325%
Tresibainsulin degludecNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.